Sugammadex: routine use vs restrictive use.
Anesthesia Recovery Period
Anesthesia, General
/ methods
Atracurium
/ therapeutic use
Cholinesterase Inhibitors
/ therapeutic use
Drug Costs
Glycopyrrolate
/ therapeutic use
Humans
Muscarinic Antagonists
/ therapeutic use
Neostigmine
/ therapeutic use
Neuromuscular Nondepolarizing Agents
/ therapeutic use
Practice Guidelines as Topic
Rocuronium
/ therapeutic use
State Medicine
Sugammadex
/ economics
United Kingdom
Journal
British journal of hospital medicine (London, England : 2005)
ISSN: 1750-8460
Titre abrégé: Br J Hosp Med (Lond)
Pays: England
ID NLM: 101257109
Informations de publication
Date de publication:
02 Jun 2020
02 Jun 2020
Historique:
pubmed:
27
6
2020
medline:
22
4
2021
entrez:
27
6
2020
Statut:
ppublish
Résumé
Worldwide, the use of sugammadex for the reversal of neuromuscular blocking agents worldwide is restricted. This article reflects on how more liberal use of sugammadex might alter patient experience, anaesthetic delivery and surgical techniques.
Identifiants
pubmed: 32589529
doi: 10.12968/hmed.2020.0014
doi:
Substances chimiques
Cholinesterase Inhibitors
0
Muscarinic Antagonists
0
Neuromuscular Nondepolarizing Agents
0
Atracurium
2GQ1IRY63P
Sugammadex
361LPM2T56
Neostigmine
3982TWQ96G
Glycopyrrolate
V92SO9WP2I
Rocuronium
WRE554RFEZ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM